WELLS FARGO & COMPANY/MN FILES (8-K) Disclosing Financial Statements and Exhibits

Edgar Glimpses |

Item 9.01. Financial Statements and Exhibits

Exhibits are filed herewith in connection with the Registration Statement on Form S-3 (File No. 333-221324) filed by Wells Fargo & Company with the Securities and Exchange Commission.

On , Wells Fargo & Company issued the following Medium-Term Notes, Series S: 0.125% Equity Basket Linked Notes due , Linked to a Basket of Shares (the "Notes").

The purpose of this Current Report is to file with the Securities and Exchange Commission the form of Note related to such issuance and the opinion of Faegre Baker Daniels LLP regarding the Notes.



  (d) Exhibits




Exhibit No.                          Description                               Location

    4.1            Form of Medium-Term Notes, Series S, 0.125%              Filed herewith
                 Equity Basket Linked Notes due February 14, 2025,
                 Linked to a Basket of Shares.

    5.1            Opinion of Faegre Baker Daniels LLP regarding the        Filed herewith
                 Notes.

   23.1            Consent of Faegre Baker Daniels LLP.                   Included as part of
                                                                              Exhibit 5.1




                                       2

--------------------------------------------------------------------------------

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

Level Headed at World Crypto Con - Steve Beauregard

Bloq.com CRO Steve Beauregard joins Jack Brewer at World Crypto Con.

Emerging Growth

Q BioMed Inc

Q BioMed Inc is a biomedical acceleration and development company. The company is a biomedical acceleration and development company focused on licensing, acquiring and providing strategic resources to life sciences…